吸入麻酔のグローバル市場2022~2030:薬剤別、用途別、地域別

■ 英語タイトル:Inhalation Anesthesia Market Size, Share & Trends Analysis By Drug (Sevoflurane, Isoflurane, Desflurane), By Application (Induction, Maintenance), By Region, And Segment Forecasts, 2022 - 2030

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GRV22JL029)■ 発行会社/調査会社:Grand View Research
■ 商品コード:GRV22JL029
■ 発行日:2022年5月19日
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:150
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後3営業日)
■ 販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[吸入麻酔のグローバル市場2022~2030:薬剤別、用途別、地域別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

グランドビューリサーチ社は、世界の吸入麻酔市場規模が2022年から2030年の間に年平均9.0%成長し、2030年までに24億ドルに達すると予測しています。本調査レポートでは、吸入麻酔の世界市場について調査し、調査手法、エグゼクティブサマリー、産業動向、薬剤別(セボフルラン、デスフルラン、イソフルラン、ハロタン)分析、用途別(誘導、維持)分析、地域別分析、競争分析などを掲載しています。本調査レポートでは、Halocarbon Products Corporation、Baxter、AbbVie、Lunan Pharmaceutical Group、Piramal Enterprises Ltd.、Sandoz International GmbH (Novartis)、Fresenius Kabi Agなどの企業情報が含まれています。
・調査手法
・エグゼクティブサマリー
・産業動向
・世界の吸入麻酔市場規模:薬剤別(セボフルラン、デスフルラン、イソフルラン、ハロタン)
・世界の吸入麻酔市場規模:用途別(誘導、維持)
・世界の吸入麻酔市場規模:地域別
・競争分析

吸入麻酔市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の吸入麻酔市場規模は2030年までに24億米ドルに達すると予想され、2022年から2030年までの予測期間においてCAGR 9.0%で拡大する見込みです。吸入麻酔薬は、他の代替品と比較して、より優れた有効性と副作用の少なさとともに、導入期間と回復時間が短いため、外科処置中に優れた麻酔効果を提供します。また、患者の麻酔時間のコントロールにも優れています。このような利点から、静脈麻酔よりも吸入麻酔が好まれています。

吸入麻酔で投与される薬剤は、静脈麻酔に比べて低用量でも作用発現が速い。吸入経路での投与は、過剰投与を避け、患者の自律神経機能を維持するのに役立ちます。これらの薬剤は肺から排出されるため、体内に蓄積される可能性が低くなります。したがって、肝毒性のリスクも低くなります。さらに、吸入経路で投与される薬剤は、他の代替経路と比較して、耐性や中毒レベルが限られています。

AnaConDa (Anaesthetic Conserving Device)のような革新的な呼吸器製品の発売により、セボフルラン、イソフルランなどの吸入全身麻酔薬の投与が容易になりました。吸入麻酔は、患者の健康状態をモニターしやすいため、24時間以上人工呼吸をしている患者にとって最良の選択肢と考えられています。

麻酔ガスに関連する主な懸念は、患者が使用するのはわずか5%で、残りの95%は大気中に放出され、これらのガスの温室効果につながることです。セボフルラン、イソフルラン、デスフルランを大気中の時間スパンと世界大気濃度に基づいて比較分析すると、デスフルランは環境に対して高い潜在的脅威をもたらすことがわかります。

吸入麻酔市場レポートハイライト

- セボフルランは、その薬物動態学および薬力学が他の代替吸入麻酔薬よりも多くの利点をもたらすという事実により、2021年に最大の市場シェアを獲得しました。

- デスフルランは、単独で、または亜酸化窒素や他の吸入麻酔薬と組み合わせて、様々な外科手術に使用されます。

- ハロタンは、ハロタン誘発性肝炎など、多くの合併症が報告されているため、欧米諸国の大半で使用が中止されています。

- セボフルランとデスフルランの需要が高いため、2021年の市場は北米が独占しました。主要企業も様々な戦略的取り組みを行っており、それが米国での高い収益成長につながっています。

- 中国はアジア太平洋地域で最大の経済大国。世界最大の人口を抱える国であるため、手術のための患者数も多いです。大規模な患者プールの存在とともに、多数の手術が実施されているため、予測期間中に市場が拡大すると予想されます。

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Research Methodology
1.1 Research Methodology
1.1.1 Information procurement
1.1.2 Purchased database:
1.1.3 GVR’s Internal Database
1.1.4 Secondary sources
1.1.5 Third-Party Perspective
1.1.6 Primary Research:
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 List of Secondary Sources
1.5 List of Primary Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Market Snapshot
Chapter 3 Industry Outlook
3.1 Market Segmentation
3.2 Market Lineage Outlook
3.2.1 Parent market outlook: Anesthesia Market
3.2.2 Related/ancillary market outlook
3.3 Penetration & Growth Prospect Mapping
3.4 User Perspective Analysis
3.4.1 Consumer Behavior Analysis
3.4.2 Market Influencer Analysis
3.5 List of Key End Users
3.6 Regulatory Framework, by Country
3.6.1 U.S.
3.6.2 Canada
3.6.3 U.K.
3.6.4 Germany
3.6.5 France
3.6.6 Italy
3.6.7 Spain
3.6.8 Japan
3.6.9 China
3.6.10 India
3.6.11 Australia
3.6.12 South Korea
3.6.13 Brazil
3.6.14 Mexico
3.6.15 Argentina
3.6.16 South Africa
3.6.17 UAE
3.6.18 Saudi Arabia
3.7 Market Driver Analysis
3.7.1 Higher patient outcome as compared to intravenous anesthesia
3.7.2 Increasing need to reduce hospital care cost
3.7.3 Rising number of surgical procedures
3.8 Market Restraint Analysis
3.8.1 Increasing concern about greenhouse gas emissions
3.9 Inhalation Anesthesia Market Analysis Tools
3.9.1 Industry Analysis – Porter’s Five Forces Analysis
3.9.1.1 Threat of new entrants
3.9.1.2 Bargaining power of suppliers
3.9.1.3 Competitive rivalry
3.9.1.4 Bargaining power of buyers
3.9.1.5 Threat of substitutes
3.10 Major Deals & Strategic Alliances Analysis
3.11 Market Entry Strategies
3.12 Inhalation Anesthesia Market – PESTL Analysis
3.13 COVID-19 Impact on Inhalation Anesthesia Market
Chapter 4 Inhalation Anesthesia Market: Drug Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Market: Drug Movement Analysis, USD Million, 2021 & 2030
4.3 Sevoflurane
4.3.1 Market Revenue Estimates and Forecasts, 2016 – 2030 (USD Million)
4.4 Desflurane
4.4.1 Market Revenue Estimates and Forecasts, 2016 – 2030 (USD Million)
4.5 Isoflurane
4.5.1 Market Revenue Estimates and Forecasts, 2016 – 2030 (USD Million)
4.6 Halothane
4.6.1 Market Revenue Estimates and Forecasts, 2016 – 2030 (USD Million)
Chapter 5 Inhalation Anesthesia Market: Application Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Market: Application Movement Analysis, USD Million, 2021 & 2030
5.3 Induction
5.3.1 Market Revenue Estimates and Forecasts, 2016 – 2030 (USD Million)
5.4 Maintenance
5.4.1 Market Revenue Estimates and Forecasts, 2016 – 2030 (USD Million)
Chapter 6 Inhalation Anesthesia Market: Regional Estimates & Trend Analysis
6.1 Regional Dashboard
6.2 Regional Market Share Analysis, By Leading Players, 2021
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 MEA
6.3 SWOT Analysis, by Factor (Political, Legal, Economic, and Technological)
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 Latin America
6.3.5 MEA
6.4 Inhalation Anesthesia Market: Regional Movement Analysis
6.5 North America
6.5.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.5.2 U.S.
6.5.2.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.5.3 Canada
6.5.3.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.6 Europe
6.6.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.6.2 U.K.
6.6.2.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.6.3 Germany
6.6.3.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.6.4 France
6.6.4.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.6.5 Italy
6.6.5.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.6.6 Spain
6.6.6.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.7 Asia Pacific
6.7.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.7.2 China
6.7.2.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.7.3 Japan
6.7.3.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.7.4 India
6.7.4.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.7.5 Australia
6.7.5.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.7.6 South Korea
6.7.6.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.8 Latin America
6.8.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.8.2 Brazil
6.8.2.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.8.3 Mexico
6.8.3.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.8.4 Argentina
6.8.4.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.9 MEA
6.9.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.9.2 South Africa
6.9.2.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.9.3 Saudi Arabia
6.9.3.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
6.9.4 UAE
6.9.4.1 Market estimates and forecasts, 2016 – 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.1.1 Halocarbon Products Corporation
7.1.2 Baxter
7.1.3 AbbVie
7.1.4 Lunan Pharmaceutical Group
7.1.5 Piramal Enterprises Ltd.
7.1.6 Sandoz International GmbH (Novartis)
7.1.7 Fresenius Kabi Ag
7.2 Company Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 List of key distributors and channel partners
7.3.2 Key customers
7.3.3 Company Market Share Analysis, 2021
7.4 Public Companies
7.4.1 Company Market Position Analysis
7.4.2 Competitive Dashboard Analysis
7.4.2.1 Market Differentiators
7.4.2.2 Synergy Analysis: Major Deals & Strategic Alliances
7.4.2.2.1 Investments
7.4.2.2.2 Partnerships
7.4.2.2.3 Merger & Acquisition
7.5 Private Companies
7.5.1 List of key emerging companies/technology disruptors/innovators
7.5.2 Regional network map
7.5.3 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.5.4 Supplier Ranking
7.6 Key Companies Profiled
7.6.1 Halocarbon Products Corporation
7.6.1.1 Company overview
7.6.1.2 Financial performance
7.6.1.3 Product benchmarking
7.6.1.4 Strategic initiatives
7.6.2 Baxter
7.6.2.1 Company overview
7.6.2.2 Financial performance
7.6.2.3 Product benchmarking
7.6.2.4 Strategic initiatives
7.6.3 AbbVie
7.6.3.1 Company overview
7.6.3.2 Financial performance
7.6.3.3 Product benchmarking
7.6.3.4 Strategic initiatives
7.6.4 Lunan Pharmaceutical Group
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.4.4 Strategic initiatives
7.6.5 Piramal Enterprises Ltd.
7.6.5.1 Company overview
7.6.5.2 Financial performance
7.6.5.3 Product benchmarking
7.6.5.4 Strategic initiatives
7.6.6 Sandoz International GmbH (Novartis)
7.6.6.1 Company overview
7.6.6.2 Financial performance
7.6.6.3 Product benchmarking
7.6.6.4 Strategic initiatives
7.6.7 Fresenius Kabi Ag
7.6.7.1 Company overview
7.6.7.2 Financial performance
7.6.7.3 Product benchmarking
7.6.7.4 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 North America inhalation anesthesia market, by country, 2016 - 2030 (USD Million)
Table 4 North America inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 5 North America inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 6 U.S. inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 7 U.S. inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 8 Canada inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 9 Canada inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 10 Europe inhalation anesthesia market, by country, 2016 - 2030 (USD Million)
Table 11 Europe inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 12 Europe inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 13 U.K. inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 14 U.K. inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 15 Germany inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 16 Germany inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 17 France inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 18 France inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 19 Italy inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 20 Italy inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 21 Spain inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 22 Spain inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 23 Asia Pacific inhalation anesthesia market, by country, 2016 - 2030 (USD Million)
Table 24 Asia Pacific inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 25 Asia Pacific inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 26 China inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 27 China inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 28 Japan inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 29 Japan inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 30 India inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 31 India inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 32 Australia inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 33 Australia inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 34 South Korea inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 35 South Korea inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 36 Latin America inhalation anesthesia market, by country, 2016 - 2030 (USD Million)
Table 37 Latin America inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 38 Latin America inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 39 Brazil inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 40 Brazil inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 41 Mexico inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 42 Mexico inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 43 Argentina inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 44 Argentina inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 45 MEA inhalation anesthesia market, by country, 2016 - 2030 (USD Million)
Table 46 MEA inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 47 MEA inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 48 South Africa inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 49 South Africa inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 50 Saudi Arabia inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 51 Saudi Arabia inhalation anesthesia, by application, 2016 - 2030 (USD Million)
Table 52 UAE inhalation anesthesia market, by drug, 2016 - 2030 (USD Million)
Table 53 UAE inhalation anesthesia, by application, 2016 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 QFD modelling for market share assessment
Fig. 7 Information analysis and market formulation process
Fig. 8 Market formulation & validation
Fig. 9 Inhalation Anesthesia Market: Market Outlook
Fig. 10 Inhalation Anesthesia Market Competitive Insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Inhalation Anesthesia Market Driver Impact (Current & future impact)
Fig. 16 Inhalation Anesthesia Market Restraint Impact (Current & future impact)
Fig. 17 Drug market share analysis, 2021 & 2030
Fig. 18 Segment Dashboard
Fig. 19 Inhalation Anesthesia Market: Drug outlook and key takeaways
Fig. 20 Sevoflurane market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 21 Desflurane market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 22 Isoflurane market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 23 Halothane market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 24 Application market share analysis, 2021 & 2030
Fig. 25 Segment Dashboard
Fig. 26 Inhalation Anesthesia Market: Application outlook and key takeaways
Fig. 27 Induction market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 28 Maintenance market estimates and forecast, 2016 - 2030 (USD Million)
Fig. 29 Global Inhalation Anesthesia Market: Regional Movement Analysis
Fig. 30 Global Inhalation Anesthesia Market: Regional Outlook And Key Takeaways
Fig. 31 Global Market Share and Leading Players
Fig. 32 North America Market Share and Leading Players
Fig. 33 Europe Market Share and Leading Players
Fig. 34 Asia Pacific Market Share and Leading Players
Fig. 35 Latin America Market Share and Leading Players
Fig. 36 Middle East & Africa Market Share and Leading Players
Fig. 37 North America Inhalation Anesthesia Market: Regional SWOT analysis
Fig. 38 Europe Inhalation Anesthesia Market: Regional SWOT analysis
Fig. 39 Asia Pacific Inhalation Anesthesia Market: Regional SWOT analysis
Fig. 40 Latin America Inhalation Anesthesia Market: Regional SWOT analysis
Fig. 41 MEA Inhalation Anesthesia Market: Regional SWOT analysis
Fig. 42 North America inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 43 U.S. inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 44 Canada inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 45 Europe inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 46 U.K. inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 47 Germany inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 48 France inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 49 Italy inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 50 Spain inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 51 Asia Pacific inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 52 China inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 53 Japan inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 54 India inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 55 Australia inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 56 South Korea inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 57 Latin America inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 58 Brazil inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 59 Mexico inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 60 Argentina inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 61 MEA inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 62 South Africa inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 63 Saudi Arabia inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 64 UAE inhalation anesthesia market estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 65 Company Categorization
Fig. 66 List of key distributors and channel partners
Fig. 67 Company market share analysis, 2021 (%)
Fig. 68 Company market position analysis
Fig. 69 List of key emerging companies/technology disruptors/innovators
Fig. 70 Regional network map
Fig. 71 Company market position analysis

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GRV22JL029 )"吸入麻酔のグローバル市場2022~2030:薬剤別、用途別、地域別" (英文:Inhalation Anesthesia Market Size, Share & Trends Analysis By Drug (Sevoflurane, Isoflurane, Desflurane), By Application (Induction, Maintenance), By Region, And Segment Forecasts, 2022 - 2030)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。